Skip to Main Content

A Phase I/II Trial of Reduced Intensity Conditioning and Familial HLA-Mismatched Bone Marrow Transplantation in Children With Non-Malignant Disorders

Conditions

Other Hematopoietic | Pediatrics

Phase I

What is the purpose of this trial?

This study is designed to estimate the efficacy and toxicity of familial HLA mismatched bone marrow transplants in patients with non-malignant disease who are less than 21 years of age and could benefit from the procedure.

  • Trial with
    Washington University School of Medicine
  • Start Date
    08/13/2021
  • End Date
    04/30/2024

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/11/2022
  • Study HIC
    #2000025196